You can’t win: The FDA is taking heat for overreacting with the Elidel warning
“This is absurd beyond imagination – not every drug is Vioxx; and the enormous evidence that was presented to the FDA demonstrated the safety of these [drugs].”
ADVERTISEMENT
More in Uncategorized
Past Week
-
Evidence-based medicine vs. clinical judgment: a medical student’s perspective
-
The controversy over Maintenance of Certification for grandfathered physicians
-
How hindsight bias distorts clinical medicine
-
When side effects are actually a cry for help with medication costs
-
Why clinician education must prioritize nutrition training
-
Why early detection matters: Transforming lung cancer care [PODCAST]
-
Past 6 Months
-
The dangers of vertical integration in health care
-
Why does sex work seem like a more viable path than medicine in 2026?
-
The 9 laws of health care quality: Why metrics miss the point
-
Politics and fear have replaced science in U.S. pain management [PODCAST]
-
From Singapore to Canada: a blueprint for primary care transformation
-
How board certification fuels the physician shortage crisis
-
Recent Posts
-
Pediatric home health care oversight: Why accountability is failing
-
Proactive monitoring can prevent emergencies by catching heart signals early [PODCAST]
-
Health care affordability crisis: lessons from the NYC nursing strike
-
How wearable technology is changing the role of physicians
-
Workplace violence against nurses: a crisis of systemic failure
-
Ignored DNR hospital policy: a family’s tragic end-of-life story
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
